Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Regardless of the primary disease responsible for kidney failure, patients suffering from chronic kidney disease (CKD) have in common multiple impairments of both the innate and adaptive immune systems, the pathophysiology of which has long remained enigmatic. CKD-associated immune dysfunction includes chronic low-grade activation of monocytes and neutrophils, which induces endothelial damage and increases cardiovascular risk. Although innate immune effectors are activated during CKD, their anti-bacterial capacity is impaired, leading to increased susceptibility to extracellular bacterial infections. Finally, CKD patients are also characterized by profound alterations of cellular and humoral adaptive immune responses, which account for an increased risk for malignancies and viral infections. This review summarizes the recent emerging data that link the pathophysiology of CKD-associated immune dysfunctions with the accumulation of microbiota-derived metabolites, including indoxyl sulfate and p-cresyl sulfate, the two best characterized protein-bound uremic retention solutes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Activation of innate immune cells leads to the release of pro-inflammatory cytokines, which have an important protective role but can turn deleterious in cases of chronic exposure [48].”
BackgroundFunctional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 1×
“The causal roles of dysbiosis in host pathophysiology like obesity, diabetes mellitus, non-alcoholic fatty-liver disease, malignancies, and major depressive disorders have been increasingly recognized [16].”
BackgroundWebster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Microbial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236 · cited 3×
“This dysbiosis [18,33] is responsible for an increased production of indoxyl sulfate (IS, transformed from indole by liver enzymes cytochrome P450 2E1 and sulfotransferase [22]), which is also less secreted by tubular epithelial cells.”
BackgroundControl of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865 · cited 1×
“Furthermore, treatment of mice with AhR ligands has also been shown to ameliorate the development of several T-cell dependent auto-immune diseases [112,113].”
BackgroundRothhammer, V., & Quintana, F. J. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0125-8 · Cited by 1,197 · cited 2×
“Upon agonist binding, the AhR complex translocates into the nucleus where it binds DNA-responsive elements to regulate gene expression [32].”
BackgroundChronic kidney disease alters intestinal microbial flora
Vaziri, N. D., Wong, J., Pahl, M., Piceno, Y. M., Yuan, J., DeSantis, T. Z., Ni, Z., Nguyen, T.-H., & Andersen, G. L. (2013) · Kidney International · doi:10.1038/ki.2012.345 · Cited by 1,164 · cited 1×
“During CKD, numerous external and internal factors associate to promote bacterial overgrowth in the small intestine and alterations in microbiota composition [17].”
BackgroundBansal, T., Alaniz, R. C., Wood, T. K., & Jayaraman, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906112107 · Cited by 868
Inflammation and Progression of CKD: The CRIC Study
Amdur, R. L., Feldman, H. I., Gupta, J., Yang, W., Kanetsky, P., Shlipak, M., Rahman, M., Lash, J. P., Townsend, R. R., Ojo, A., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13121215 · Cited by 452 · cited 24×
“DCs are found in reduced number in the circulation of CKD pati nts [80,81] and t is decrease has been shown to parallel the decline in GFR [82].”
BackgroundInfluentialCommensal bacteria-dependent indole production enhances epithelial barrier function in the colon
Shimada, Y., Kinoshita, M., Harada, K., Mizutani, M., Masahata, K., Kayama, H., & Takeda, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080604 · Cited by 404
Cited by
Stachulski, A. V., Knausenberger, T. B.-A., Shah, S. N., Hoyles, L., & McArthur, S. (2023) · Tissue Barriers · doi:10.1080/21688370.2022.2073175 · Cited by 61
Metadata
- Authors
- Espi, M., Koppe, L., Fouque, D., & Thaunat, O.
- Venue
- Toxins
- Publisher
- MDPI AG
- Published
- 2020-05-06
- Volume
- 12
- Issue
- 5
- Pages
- 300
- ISSN
- 2072-6651 (ISSN-L)
- OpenAlex
- W3023658945
- Cited by
- 175
- References
- 15
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells. https://app.cochat.ai/papers/10.3390/toxins12050300
- The paper
- Espi, M., Koppe, L., Fouque, D., & Thaunat, O. (2020). Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells. Toxins. https://doi.org/10.3390/toxins12050300
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.